EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report

Mihoko Kawai iD, Jun Miyata, Kousuke Kanemoto

Psychiatry and Clinical Neurosciences Reports · 2026-06 · 5 (2)

DOI: 10.1002/pcn5.70335 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 27.04.2026. Verfasst von Mihoko Kawai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry Aichi Medical University Nagakute Aichi Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Levetiracetam and brivaracetam (BRV) are antiseizure medications that exert effects by binding to synaptic vesicle protein 2A (SV2A). BRV exhibits higher affinity and selectivity for SV2A and is generally considered to have a favorable psychiatric tolerability profile. However, reports on serious psychiatric adverse events remain scarce. Case Presentation We herein report a 60‐year‐old man with a history of bipolar disorder who had remained psychiatrically stable for many years under aripiprazole treatment. He was diagnosed with focal epilepsy based on stereotyped focal seizures with impaired awareness and right temporal epileptiform discharges observed on electroencephalography. BRV was initiated at a dose of 50 mg/day and later increased to 100 mg/day. Several weeks after initiation, he developed elevated mood, marked irritability, emotional dysregulation, and delusion‐like ideation, progressing to a manic episode with psychotic features requiring inpatient psychiatric care. BRV was discontinued and replaced with lacosamide, coupled with intensification of a mood‐stabilizing treatment, which resulted in the gradual resolution of manic symptoms. No epileptic seizures occurred during BRV treatment or after the medication switch.

Conclusion

This case suggests that, despite its generally favorable psychiatric tolerability, BRV may be associated with the emergence of symptoms in patients with bipolar disorder. These findings highlight the importance of careful psychiatric risk assessment and close monitoring when initiating BRV in individuals with underlying mood vulnerability.

Schlagwörter

Stichwörter der Autor:innen

bipolar disorderbrivaracetamepilepsymanic episodepsychiatric adverse events

Autor:innen und Institutionen

  • Department of Psychiatry Aichi Medical University Nagakute Aichi Japan.
  • Epilepsy, Psychiatry Suzukake Clinic Nagoya Aichi Japan.

ORCID-Profile: Mihoko Kawai

Zitieren

APA

Kawai, M., Miyata, J., & Kanemoto, K. (2026). Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report. Psychiatry and Clinical Neurosciences Reports, 5(2). https://doi.org/10.1002/pcn5.70335

Vancouver

Kawai M, Miyata J, Kanemoto K. Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report. Psychiatry and Clinical Neurosciences Reports. 2026;5(2). doi:10.1002/pcn5.70335

BibTeX
@article{Kawai2026,
  author = {Kawai, Mihoko and Miyata, Jun and Kanemoto, Kousuke},
  title = {Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report},
  journal = {Psychiatry and Clinical Neurosciences Reports},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.1002/pcn5.70335}
}
Kostenlos starten →